Glucotrack(us:GCTK)

    0.2935

    +32.39%

    Updated on 2024-12-22

    Open:0.2300
    Close:0.2935
    High:0.2935
    Low:0.2202
    Pre Close:0.2217
    Volume:514498.00
    Amount:130079.72
    Turnover:3.21%
    Shares:16.05M
    MarketCap:4.71M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-309299470.55%207
    2024-03-31111569450.59%315
    2023-12-31106077452.91%125
    2023-09-309226446510.84%412
    2023-06-308215193810.30%413
    2023-03-315544190.35%012
    2022-12-315484190.31%200
    2022-09-304380720.25%101
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Sabby Management, Llc1229270.46%3714543.30%
    2024-03-31Alerus Financial Na138560.05%0
    2024-03-31Virtue Capital Management, Llc60000.02%6000
    2024-03-31Accurate Wealth Management, Llc44200.02%0
    2024-03-31Citadel Advisors Llc44050.02%-3432-43.79%
    2024-03-31Susquehanna International Group, Llp27370.01%2737
    2024-03-31Renaissance Technologies Llc26000.01%2600
    2024-03-31Boston Financial Mangement Llc0-5274
    2024-03-31Virtu Financial Llc0-3783
    2024-03-31Ubs Group Ag0-960

    About

    GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.
    Address:301 Route 17 North,Suite 800

    Market Movers